Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.
about
Antihypertensive drug therapy for mild to moderate hypertension during pregnancyAntihypertensive drug therapy for mild to moderate hypertension during pregnancyRole of central beta-adrenoceptors in the control of pentylenetetrazol-induced convulsions in ratsSudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trialβ-Adrenergic blockade in cardiovascular disease.Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.Pindolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.Celiprolol: A Unique Selective Adrenoceptor Modulator.The mechanisms of antihypertensive action of beta-adrenergic receptor blocking drugs.Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).Beta1- or beta2-blockers to improve hemodynamics following endotracheal adrenaline administration.Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.A simplified mechanistic algorithm for treating resistant hypertension: efficacy in a retrospective study.
P2860
Q24200520-F9D2DFF5-34AF-4513-A9B0-27BBBA93BD47Q24246376-5BA34F1A-80A4-4C9E-A970-AB8A68FC4ECCQ36128025-80127430-316F-427F-A9FC-3316DCBB140AQ36684008-530B8BAF-858A-4E67-BD51-E2A452514207Q36758705-1EFDCA01-CE88-4679-9ED0-20C8C7D76533Q38103516-D01ED449-D780-49D7-8C1A-92D75A12AFF1Q38586842-BE318C37-3B1F-40BA-8149-B45DA74E4139Q40090048-7E9F3CA9-AD16-4AB8-8035-F1EB1E889617Q41322349-93F802CD-783D-4CBA-88C3-BF1BF8FCC774Q41465541-D3E6175C-72A2-4EB3-A056-00CFA4242368Q41964457-83D44DCF-B874-4571-B6C4-C1000F0CD58DQ43241458-83E7965E-05ED-4627-9495-A4DE56918C52Q46639825-26018DCC-D2DF-4F01-9767-6708F94D5AA9Q46743813-EA62B17D-745B-4684-B466-D61D624884FDQ51393136-D57B965A-E794-4B86-9E4E-2007400BCF37
P2860
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Clinical pharmacology of the n ...... nd pharmacokinetic properties.
@en
Clinical pharmacology of the n ...... nd pharmacokinetic properties.
@nl
type
label
Clinical pharmacology of the n ...... nd pharmacokinetic properties.
@en
Clinical pharmacology of the n ...... nd pharmacokinetic properties.
@nl
prefLabel
Clinical pharmacology of the n ...... nd pharmacokinetic properties.
@en
Clinical pharmacology of the n ...... nd pharmacokinetic properties.
@nl
P1476
Clinical pharmacology of the n ...... nd pharmacokinetic properties.
@en
P2093
Frishman W
P304
P356
10.1016/0002-8703(79)90195-9
P407
P577
1979-05-01T00:00:00Z